Vanguard Group Inc Sarepta Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 8,795,754 shares of SRPT stock, worth $1.39 Billion. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,795,754
Previous 8,816,124
0.23%
Holding current value
$1.39 Billion
Previous $850 Million
33.94%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Black Rock Inc. New York, NY5.96MShares$942 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$773 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$761 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$686 Million6.78% of portfolio
-
Wellington Management Group LLP Boston, MA3.25MShares$513 Million0.08% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.8B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...